Skip to main
ASPI

ASPI Stock Forecast & Price Target

ASPI Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ASP Isotopes Inc is demonstrating substantial revenue growth, with a reported revenue of approximately $4.9 million for the recent quarter, reflecting a remarkable annual increase of about 345.5% and a sequential rise of approximately 308.3%. Additionally, the company is positioned well within the helium market, which is forecasted to see a doubling in demand by 2035, providing substantial opportunities for long-term revenue growth amidst an expanding market valued at around USD 132 million by 2025, growing at a CAGR of 5.8% through 2033. The validation of ASP's laser-based quantum enrichment technology through its success with ytterbium-176 reinforces confidence in the company's ability to meet advanced nuclear fuel demands, suggesting a potential for several-fold scale growth if management successfully executes its strategy.

Bears say

ASP Isotopes Inc is facing a challenging financial situation as demonstrated by a significant decline in gross margin to approximately 8.7%, well below estimates and previous performance metrics, indicating operational inefficiencies. The company's net loss widened year-over-year to $12.1 million, alongside delays in revenue generation tied to postponed deliveries of critical isotopes, which further exacerbates liquidity concerns. Furthermore, external economic factors such as increased interest rates, inflation, and market volatility contribute to pressure on the firm, complicating its ability to implement its strategic development programs effectively.

ASPI has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ASP Isotopes Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ASP Isotopes Inc (ASPI) Forecast

Analysts have given ASPI a Buy based on their latest research and market trends.

According to 2 analysts, ASPI has a Buy consensus rating as of Jan 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ASP Isotopes Inc (ASPI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.